Asia-Pacific is becoming central to global clinical development strategy, offering access to diverse patient populations and, in select markets, faster enrollment. However, regulatory maturity, infrastructure readiness, and cultural considerations differ significantly across countries.

This executive summary shares insights from industry leaders on how sponsors can navigate regional complexity and design trials that align with local realities.